Quest for Growth

Type

Venture Capital

Location

Leuven, Belgium

Total investments

31

Average round size

18M

Portfolio companies

25

Rounds per year

1.29

Follow on index

0.19

Exits

13

Stages of investment
Early Stage VentureLate Stage Venture
Areas of investment
BiotechnologySoftwareHealth CareHealth DiagnosticsManufacturingMedical DeviceMedicalPharmaceuticalHardwareBiopharma

Summary

Quest for Growth appeared to be the VC, which was created in 1999. The leading representative office of defined VC is situated in the Leuven. The venture was found in Europe in Belgium.

The typical case for the fund is to invest in rounds with 5-6 participants. Despite the Quest for Growth, startups are often financed by BioMedPartners, Crescendo Ventures, VI Partners AG. The meaningful sponsors for the fund in investment in the same round are Capricorn Venture Partners, Gimv, Life Sciences Partners. In the next rounds fund is usually obtained by RUSNANO, Gimv, Kreos Capital.

Opposing the other organizations, this Quest for Growth works on 21 percentage points more the average amount of lead investments. The high activity for fund was in 2007. The fund is constantly included in less than 2 investment rounds annually. Deals in the range of 10 - 50 millions dollars are the general things for fund. The higher amount of exits for fund were in 2015.

For fund there is a match between the country of its foundation and the country of its the most frequent investments - Belgium. Among the most popular portfolio startups of the fund, we may highlight Plastic Logic Germany, Kiadis Pharma, Miracor Medical. Among the most popular fund investment industries, there are Medical Device, Finance. The fund has specific favorite in a number of founders of portfolio startups. Besides, a startup requires to be at the age of 6-10 years to receive the investment from the fund.

The overall number of key employees were 1.

Show more

Investor highlights

Geo focus
AlbaniaAustriaBelgiumBosnia and HerzegovinaBulgaria Show 36 more

Discover reliable insights

Find relevant VC investors, identify key contacts and secure funding opportunities.

Investments analytics

Analytics

Total investments
31
Lead investments
0
Exits
13
Rounds per year
1.29
Follow on index
0.19
Investments by industry
  • Biotechnology (10)
  • Pharmaceutical (8)
  • Health Care (7)
  • Software (6)
  • Hardware (5)
  • Show 41 more
Investments by region
  • Germany (3)
  • Belgium (10)
  • United Kingdom (4)
  • Netherlands (4)
  • France (4)
  • Show 4 more
Peak activity year
2007

Discover reliable insights

Leverage validated data, identify key contacts and secure funding opportunities for your business.

Quantitative data

Avg. startup age at the time of investment
19
Avg. valuation at time of investment
84M
Group Appearance index
1.00
Avg. company exit year
9
Avg. multiplicator
4.07
Strategy success index
0.30

Need more data?

Get access to full data about investors, including their team, contact information, and historic data.

Latest deals

Company name Deal date Industry Deal stage Deal size Location
Qpinch 09 Sep 2021 Energy, Renewable Energy, Energy Efficiency, Clean Energy Early Stage Venture 16M Antwerpen, Antwerp, Belgium
Sequana Medical 23 Oct 2015 Biotechnology, Health Care, Manufacturing, Medical Device Late Stage Venture 9M Switzerland, Zurich, Zurich

Similar funds

By same location

By same geo focus

By doing lead investments

How we get our data

At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).

Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.